This study aims to better understand how viral infections, like anogenital herpes, COVID-19, and herpes labialis, affect both healthy people and those with weakened immune systems (immunocompromised). Researchers will collect samples and analyze immune function or review existing medical reports to learn more about how these viruses behave, especially how they might change over time or develop resistance to treatments. This information could help improve ways to control and prevent viral infections. The study is open to people aged 6 months to 120 years old. The goal is to enroll 1000 participants. The current recruitment status is unclear.

Study design

This is an observational study, meaning no specific interventions are given. It aims to enroll 1000 participants.

What's involved

Participants will provide samples for analysis of immune function, or their tissue biopsies or clinical reports from outside laboratories will be reviewed. The duration of participation is open-ended.

Compensation

Not stated in the trial record.

Follow-up

Sample collection and analysis are measured at open-ended timeframes, suggesting ongoing follow-up.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.